第 1 到 97 筆結果,共 97 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis | Sunami, Kazutaka; Ikeda, Takashi; SHANG-YI HUANG ; Wang, Ming-Chung; Koh, Youngil; Min, Chang Ki; Yeh, Su-Peng; Matsumoto, Morio; Uchiyama, Michihiro; Iyama, Satoshi; Shimazaki, Chihiro; Lee, Jae Hoon; Kim, Kihyun; Kaneko, Hitomi; Kim, Jin Seok; Lin, Tung-Liang; Campana, Frank; Tada, Keisuke; Iida, Shinsuke; Suzuki, Kenshi | Clinical lymphoma, myeloma & leukemia | 0 | 0 | |
2 | 2021 | Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial | Suzuki, Kenshi; Min, Chang-Ki; Kim, Kihyun; Lee, Je-Jung; Shibayama, Hirohiko; Ko, Po-Shen; SHANG-YI HUANG ; Li, Sin-Syue; Ding, Bifeng; Khurana, Monica; Iida, Shinsuke | International journal of hematology | 4 | 5 | |
3 | 2021 | Survival, health care resource utilization and expenditures of first-line treatments for multiple myeloma patients ineligible for transplant in Taiwan | Cheng C.-N.; SHANG-YI HUANG ; Lien P.-W.; Huang S.-T.; FANG-JU LIN | PLoS ONE | 0 | 0 | |
4 | 2021 | Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan | Hung Y.-C.; Gau J.-P.; SHANG-YI HUANG ; BOR-SHENG KO ; Teng C.-L.J. | Frontiers in Oncology | 0 | 0 | |
5 | 2020 | Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis | SHANG-YI HUANG ; Yoon S.-S.; Shimizu K.; Chng W.J.; Chang C.-S.; Wong R.S.-M.; Gao S.; Wang Y.; Gordon S.W.; Glennane A.; Min C.-K. | Advances in Therapy | 11 | 8 | |
6 | 2020 | Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008–2013 | Chen, Chien-Yuan ; WANG-HUEI SHENG ; FENG-MING TIEN ; PO-CHU LEE ; SHANG-YI HUANG ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN ; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 24 | 24 | |
6007 | 2019 | Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study | JIA-HAU LIU ; Liao, X.-W.; CHIEN-HUNG CHEN ; MING YAO ; Li, C.-C.; Lin, C.-T.; CHENG-HONG TSAI ; WEN-CHIEN CHOU ; HSIN-AN HOU ; SHANG-YI HUANG ; SHANG-JU WU ; YAO-CHANG CHEN ; HWEI-FANG TIEN ; JIH-LUH TANG ; BOR-SHENG KO | British Journal of Haematology | 8 | 6 | |
6008 | 2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
6009 | 2019 | Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network | Soekojo C.Y.; Kim K.; SHANG-YI HUANG ; Chim C.-S.; Takezako N.; Asaoku H.; Kimura H.; Kosugi H.; Sakamoto J.; Gopalakrishnan S.K.; Nagarajan C.; Wei Y.; Moorakonda R.; Lee S.L.; Lee J.J.; Yoon S.-S.; Kim J.S.; Min C.K.; Lee J.-H.; Durie B.; Chng W.J. | Blood Cancer Journal | 12 | 7 | |
6010 | 2019 | Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries | Hungria V.T.M.; Lee J.H.; Maiolino A.; de Queiroz Crusoe E.; Martinez G.; Bittencourt R.; Duarte G.O.; Fantl D.B.; Navarro J.R.; Conte G.; Gomez-Almaguer D.; Ruiz-Argüelles G.J.; Kim K.; Shimizu K.; Chen W.; SHANG-YI HUANG ; Chng W.-J.; Chim C.S.; Nawarawong W.; Durie B. | Annals of Hematology | 9 | 6 | |
6011 | 2019 | Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma | Spicka I.; Ocio E.M.; Oakervee H.E.; Greil R.; Banh R.H.; SHANG-YI HUANG ; D'Rozario J.M.; Dimopoulos M.A.; Martínez S.; Extremera S.; Kahatt C.; Alfaro V.; Carella A.M.; Meuleman N.; Hájek R.; Symeonidis A.; Min C.-K.; Cannell P.; Ludwig H.; Sonneveld P.; Mateos M.V. | Annals of Hematology | 38 | 33 | |
6012 | 2019 | Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry | Huang T.-C.; SHANG-YI HUANG ; MING YAO ; Lin C.-Y.; Hwang W.-L.; Gau J.-P.; Tan T.-D.; Wang P.-N.; Liu Y.-C.; Lin S.-C.; Kao R.-H.; Pei S.-N.; Yu M.-S.; Lin H.-Y.; Su Y.-C.; Chen C.-C.; Li S.-S.; Wu Y.-Y. | Journal of the Formosan Medical Association | 3 | 0 | |
6013 | 2019 | Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma | SHANG-YI HUANG ; Chen T.-Y.; Kuo C.-Y.; Chen Y.-C.; Lin S.-F.; Chang M.-C.; Lv X.; Yang B.; Chang C.-S. | Oncology reviews | 2 | 3 | |
6014 | 2019 | Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial | Dimopoulos M.A.; Gay F.; Schjesvold F.; Beksac M.; Hajek R.; Weisel K.C.; Goldschmidt H.; Maisnar V.; Moreau P.; Min C.K.; Pluta A.; Chng W.-J.; Kaiser M.; Zweegman S.; Mateos M.-V.; Spencer A.; Iida S.; Morgan G.; Suryanarayan K.; Teng Z.; Skacel T.; Palumbo A.; Dash A.B.; Gupta N.; Labotka R.; Rajkumar S.V.; Bar D.; Basso A.; Fantl D.; He S.; Horvath N.; Lee C.; Rowlings P.; Taylor K.; Cochrane T.; Kwok F.; Ramanathan S.; Agis H.; Zojer N.; Kentos A.; Offner F.; Van Droogenbroeck J.; Wu K.L.; Maiolino A.; Martinez G.; Zanella K.; Capra M.; Araújo S.; Gregora E.; Pour L.; Scudla V.; Spicka I.; Abildgaard N.; Andersen N.; Jensen B.A.; Helleberg C.; Plesner T.; Salomo M.; Svirskaite A.; Delarue R.; Blau I.; Schieferdecker A.; Teleanu V.; Munder M.; Röllig C.; Salwender H.-J.; Fuhrmann S.; Weisel K.; Duerig J.; Zeis M.; Klein S.; Reimer P.; Schmidt C.; Scheid C.; Mayer K.; Hoffmann M.; Sosada M.; Dimopoulos A.; Delimpasi S.; Kyrtsonis M.-C.; Anagnostopoulos A.; Nagy Z.; Illés Á; Egyed M.; Borbényi Z.; Mikala G.; Dally N.; Horowitz N.; Gutwein O.; Nemets A.; Vaxman I.; Shvetz O.; Trestman S.; Ruchlemer R.; Nagler A.; Tadmor T.; Rouvio O.; Preis M.; Cavo M.; De Rosa L.; Musto P.; Cafro A.; Tosi P.; Offidani M.; Corso A.; Rossi G.; Liberati A.M.; Bosi A.; Suzuki K.; Nakaseko C.; Ishikawa T.; Matsumoto M.; Nagai H.; Sunami K.; Chou T.; Akashi K.; Takezako N.; Hagiwara S.; Eom H.S.; Jo D.-Y.; Kim J.S.; Lee J.H.; Yoon S.S.; Yoon D.H.; Kim K.; Levin M.-D.; Vellenga E.; Minnema M.; Waage A.; Haukås E.; Grosicki S.; Pluta A.; Robak T.; Marques H.; Bergantim R.; Campilho F.; Chng W.J.; Goh Y.T.; McDonald A.; Rapoport B.; Álvarez Rivas M.A.; De Arriba de La Fuente F.; González Montes Y.; Martin Sanchez J.; Mateos M.V.; Oriol Rocafiguera A.; Rosinol L.; San Miguel J.; Pérez de Oteyza J.; Encinas C.; Alegre-Amor A.; López-Guía A.; Axelsson P.; Carlson K.; Stromberg O.; Hansson M.; Hveding Blimark C.; Mueller R.; Chen C.-C.; Liu T.-C.; SHANG-YI HUANG ; Wang P.-N.; Na Nakorn T.; Prayongratana K.; Unal A.; Goker H.; Sonmez M.; Korenkova S.; Chaidos A.; Oakervee H.; Sati H.; Benjamin R.; Wechalekar A.; Garg M.; Ramasamy K.; Cook G.; Chantry A.; Jenner M.; Buadi F.; Berryman R.; Janakiram M.; TOURMALINE-MM3 study group | The Lancet | 181 | 167 | |
6015 | 2019 | Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. Trials | Dimopoulos M.A.; Moreau P.; Iida S.; SHANG-YI HUANG ; Takezako N.; Chng W.J.; Zahlten-Kumeli A.; Sersch M.A.; Li J.; Huang M.; Lee J.H. | International Journal of Hematology | 11 | 11 | |
6016 | 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
6017 | 2018 | Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Li, Chi-Cheng; Lin, Chien-Ting; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | European Journal of Haematology | 29 | 23 | |
6018 | 2018 | Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop | Tan D.; Lee J.H.; Chen W.; Shimizu K.; Hou J.; Suzuki K.; Nawarawong W.; SHANG-YI HUANG ; Sang Chim C.; Kim K.; Kumar L.; Malhotra P.; Chng W.J.; Durie B.; for the Asian Myeloma Network | Leukemia and Lymphoma | 16 | 13 | |
6019 | 2018 | Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome | MING-EN LIN ; HSIN-AN HOU ; CHENG-HONG TSAI ; SHANG-JU WU ; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; Li C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin C.-T.; HWEI-FANG TIEN | Clinical Epigenetics | 31 | 25 | |
20 | 2018 | Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: Subgroup analyses of the phase 3 POLLUX study | Suzuki K.; Dimopoulos M.A.; Takezako N.; Okamoto S.; Shinagawa A.; Matsumoto M.; Kosugi H.; Yoon S.-S.; SHANG-YI HUANG ; Qin X.; Qi M.; Iida S. | Blood Cancer Journal | 21 | 23 | |
21 | 2018 | Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma | SHANG-YI HUANG ; Chang C.-S.; Liu T.-C.; Wang P.-N.; Yeh S.-P.; Ho C.-L.; Kuo M.-C.; Lin H.-Y.; de Jong J.; Chen J.-Y.; Yang Y.-W. | Hematological Oncology | 1 | 2 | |
22 | 2018 | GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chiu, Yu-Chiao; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; LIANG-IN LIN ; Lin, Chien-Ting; SHANG-JU WU ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-YI HUANG ; MING YAO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 29 | ||
23 | 2018 | Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan | Chen, Chien-Yuan ; FENG-MING TIEN ; ARISTINE CHENG ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; MING YAO ; JIH-LUH TANG ; HWEI-FANG TIEN ; WANG-HUEI SHENG | BMC Gastroenterology | 23 | 23 | |
24 | 2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | FENG-MING TIEN ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chen, Chien-Yuan ; CHENG-HONG TSAI ; MING YAO ; Lin, Chien-Ting; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; JIA-HAU LIU ; SHENG-CHIEH CHOU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 25 | 21 | |
25 | 2018 | Infiltration of tumor associated macrophages in multiple myeloma and its clinical significance | Gui Q.L.; Wang Y.S.; SHANG-YI HUANG ; Wan Y.; Wang H.P.; Zhu Z.G.; Li M.M.; Zhu H.Y.; Tao Q.S.; Shen Y.Y.; Zhang Q.; Qin H. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 1 | 0 | |
26 | 2017 | Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia | CHENG-HONG TSAI ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chiu, Yu-Chiao; CHIEN-CHIN LIN ; Liu, Chieh-Yu; Tseng, Mei-Hsuan; Lin, Tzung-Yi; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin, Chien-Ting; SHANG-JU WU ; Chen, Chien-Yuan ; WOEI TSAY ; ERIC YAO-YU CHUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 35 | 33 | |
27 | 2017 | Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma | Raje N.S.; Moreau P.; Terpos E.; Benboubker L.; Grząśko N.; Holstein S.A.; Oriol A.; SHANG-YI HUANG ; Beksac M.; Kuliczkowski K.; Tai D.F.; Wooldridge J.E.; Conti I.; Kaiser C.J.; Nguyen T.S.; Cronier D.M.; Palumbo A. | British Journal of Haematology | 38 | 33 | |
28 | 2017 | Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial | Lu J.; Lee J.H.; SHANG-YI HUANG ; Qiu L.; Lee J.-J.; Liu T.; Yoon S.-S.; Kim K.; Shen Z.X.; Eom H.S.; Chen W.M.; Min C.K.; Kim H.J.; Lee J.O.; Kwak J.Y.; Yiu W.; Chen G.; Ervin-Haynes A.; Hulin C.; Facon T. | British Journal of Haematology | 10 | 11 | |
29 | 2017 | Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013 | Chen, Chien-Yuan ; FENG-MING TIEN ; WANG-HUEI SHENG ; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 36 | 28 | |
30 | 2017 | Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial | Bahlis N.J.; Corso A.; Mugge L.-O.; Shen Z.-X.; Desjardins P.; Stoppa A.-M.; Decaux O.; De Revel T.; Granell M.; Marit G.; Nahi H.; Demuynck H.; SHANG-YI HUANG ; Basu S.; Guthrie T.H.; Ervin-Haynes A.; Marek J.; Chen G.; Facon T. | Leukemia | 18 | 16 | |
31 | 2017 | A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan | SHANG-YI HUANG ; Yu Y.-B.; Yeh S.-P.; Chen T.-Y.; Kao W.-Y.; Chen C.-C.; Wang M.-C.; Lin H.-Y.; Lin S.-F.; Lin T.-H.; Hua Y.; Puccio-Pick M.; DeMarco D.; Jacques C.; Dunn P. | Journal of the Formosan Medical Association | 2 | 2 | |
32 | 2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
33 | 2016 | Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma | SHANG-YI HUANG ; Lin, Hsiu-Hsia; CHUNG-WU LIN ; Li, Chi-Cheng; MING YAO ; JIH-LUH TANG ; HSIN-AN HOU ; WOEI TSAY ; Chou, Sheng-Je; Chieh-Lung Cheng ; HWEI-FANG TIEN | Oncotarget | 26 | 26 | |
34 | 2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | CHENG-HONG TSAI ; HSIN-AN HOU ; JIH-LUH TANG ; Liu, C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, M.-H.; Chiang, Y.-C.; Kuo, Y.-Y.; Liu, M.-C.; Liu, C.-W.; LIANG-IN LIN ; WOEI TSAY ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; HWEI-FANG TIEN | Leukemia | 101 | 90 | |
35 | 2016 | Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation | YUN CHIANG ; CHENG-HONG TSAI ; SUNG-HSIN KUO ; Liu, Chieh-Yu; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; Lin, Chien-Ting; HSIN-AN HOU ; WEN-CHIEN CHOU ; JIA-HAU LIU ; CHIEN-CHIN LIN ; SHANG-JU WU ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; YUNG-LI YANG ; HSIU-HAO CHANG ; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; SHENG-CHIEH CHOU ; Chieh-Lung Cheng ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN ; JIH-LUH TANG ; YU-HSUAN CHEN | Scientific Reports | 18 | 15 | |
36 | 2016 | Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells | Hung K.-H.; Su S.-T.; Chen C.-Y.; Hsu P.-H.; SHANG-YI HUANG ; Wu W.-J.; Chen M.-J.M.; Chen H.-Y.; Wu P.-C.; Lin F.-R.; Tsai M.-D.; CHIEN-YU CHEN | Cell Death and Differentiation | 21 | 20 | |
37 | 2016 | Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia | HSIN-AN HOU ; Liu, Chieh-Yu; Kuo, Yuan-Yeh; WEN-CHIEN CHOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; LIANG-IN LIN ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; JIH-LUH TANG ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, Chien-Ting; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Oncotarget | 67 | 62 | |
38 | 2015 | TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution | HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo, Y.-Y.; Liu, C.-Y.; LIANG-IN LIN ; Tseng, M.-H.; Chiang, Y.-C.; Liu, M.-C.; Liu, C.-W.; JIH-LUH TANG ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood Cancer Journal | 113 | 111 | |
39 | 2015 | Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults | Chieh-Lung Cheng ; Li, Chi-Cheng; HSIN-AN HOU ; Fang, Wei-Quan; Chang, Chin-Hao; Lin, Chien-Ting; JIH-LUH TANG ; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | BMC cancer | 42 | 40 | |
40 | 2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | YIN-KAI CHEN ; HSIN-AN HOU ; JIH-LUH TANG ; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; CHUNG-WU LIN ; Chuang S.-S.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | PLoS ONE | 7 | 4 | |
41 | 2015 | High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan | JIH-LUH TANG ; HSIANG-CHI KUNG ; Lei W.-C.; MING YAO ; UN-IN WU ; SZU-CHUN HSU ; Lin C.-T.; Li C.-C.; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG ; BOR-SHENG KO ; HWEI-FANG TIEN | PLoS ONE | 48 | 42 | |
42 | 2015 | Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study | SHANG-YI HUANG ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; SZU-CHUN HSU ; BOR-SHENG KO ; Lu H.-Y.; WOEI TSAY ; HWEI-FANG TIEN | PLoS ONE | 10 | 9 | |
43 | 2015 | GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution | HSIN-AN HOU ; YUN-CHU LIN ; Kuo Y.-Y.; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Annals of Hematology | 21 | 20 | |
44 | 2015 | A study of 65 patients with acquired hemophilia A in Taiwan | SHANG-YI HUANG ; WOEI TSAY ; Lin S.-Y.; SZU-CHUN HSU ; Hung M.-H.; MING-CHING SHEN | Journal of the Formosan Medical Association | 23 | 22 | |
45 | 2014 | Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma | SHANG-YI HUANG ; CHUNG-WU LIN ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; YAO-CHANG CHEN ; Lu H.-Y.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; WOEI TSAY ; Chou S.-J.; HWEI-FANG TIEN | Annals of Hematology | 53 | 48 | |
46 | 2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen, Chien-Yuan ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 75 | 69 | |
47 | 2014 | Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study | Kim K.; Lee J.H.; Kim J.S.; Min C.K.; Yoon S.S.; Shimizu K.; Chou T.; Kosugi H.; Suzuki K.; Chen W.; Hou J.; Lu J.; Huang X.-J.; SHANG-YI HUANG ; Chng W.J.; Tan D.; Teoh G.; Chim C.S.; Nawarawong W.; Siritanaratkul N.; Durie B.G. | American Journal of Hematology | 79 | 75 | |
48 | 2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
49 | 2014 | IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients | YI-TSUNG YANG ; HSIN-AN HOU ; Liu C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG ; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Lin C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 19 | 16 | |
50 | 2014 | SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; SHANG-JU WU ; Liu C.-Y.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; SZU-CHUN HSU ; BOR-SHENG KO ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 30 | 26 | |
51 | 2014 | The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapy | Lin H.-H.; Hwang S.-M.; SHANG-JU WU ; Hsu L.-F.; YI-HUA LIAO ; YI-SHUAN SHEEN ; Chuang W.-H.; SHANG-YI HUANG | PLoS ONE | 10 | 8 | |
52 | 2014 | Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations | SHENG-CHIEH CHOU ; JIH-LUH TANG ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Hu F.-C.; Chen, Chien-Yuan ; MING YAO ; BOR-SHENG KO ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia Research | 18 | 18 | |
53 | 2014 | Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia | HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; JIH-LUH TANG ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia | 77 | 73 | |
54 | 2013 | Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia | Chieh-Lung Cheng ; HSIN-AN HOU ; Lee, Ming-Cheng; Liu, Chieh-Yu; Jhuang, Jie-Yang; Lai, Yan-Jun; CHUNG-WU LIN ; Chen, Huan-Yuan; Liu, Fu-Tong; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 50 | 38 | |
55 | 2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 59 | 42 | |
56 | 2013 | Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia | Chen, Chien-Yuan ; ARISTINE CHENG ; SHANG-YI HUANG ; WANG-HUEI SHENG ; JIA-HAU LIU ; BOR-SHENG KO ; MING YAO ; WEN-CHIEN CHOU ; Lin H.-C.; YEE-CHUN CHEN ; WOEI TSAY ; JIH-LUH TANG ; SHAN-CHWEN CHANG ; HWEI-FANG TIEN | PLoS ONE | 44 | 39 | |
57 | 2013 | Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10 | Chen, Chien-Yuan ; SHANG-YI HUANG ; JIH-LUH TANG ; WOEI TSAY ; MING YAO ; BOR-SHENG KO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 26 | 25 | |
58 | 2012 | Intracranial hemorrhage in adult patients with hematological malignancies | Chen, Chien-Yuan ; CHUN-HWEI TAI ; ARISTINE CHENG ; Wu H.-C.; WOEI TSAY ; JIA-HAU LIU ; Chen P.-Y.; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; HWEI-FANG TIEN | BMC Medicine | 56 | 48 | |
59 | 2012 | Mycobacterial infections in adult patients with hematological malignancy | Chen, Chien-Yuan ; WANG-HUEI SHENG ; Lai C.-C.; Liao C.-H.; YU-TSUNG HUANG ; WOEI TSAY ; SHANG-YI HUANG ; JIH-LUH TANG ; HWEI-FANG TIEN ; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 32 | 25 | |
60 | 2012 | Correlation among DCE-MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma | SHANG-YI HUANG ; BANG-BIN CHEN ; Lu H.-Y.; Lin H.-H.; Wei S.-Y.; SZU-CHUN HSU ; TIFFANY TING-FANG SHIH | American Journal of Hematology | 17 | 11 | |
8061 | 2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 197 | 184 | |
8062 | 2012 | ASK1 promotes apoptosis of normal and malignant plasma cells | Lin F.-R.; SHANG-YI HUANG ; Hung K.-H.; Su S.-T.; Chung C.-H.; Matsuzawa A.; Hsiao M.; Ichijo H.; Lin K.-I. | Blood | 24 | 21 | |
8063 | 2012 | Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010 | Chen, Chien-Yuan ; SHANG-YI HUANG ; WOEI TSAY ; MING YAO ; JIH-LUH TANG ; BOR-SHENG KO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 28 | 22 | |
8064 | 2012 | A study of 46 patients with acquired haemophilia A in Taiwan finds elevated LDH level and mucosal bleedings associated with reduced response to immunosuppressive therapy | SHANG-YI HUANG ; WOEI TSAY ; Lin H.-Y.; SZU-CHUN HSU ; MING-CHING SHEN | Haemophilia | 2 | 2 | |
8065 | 2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 124 | 100 | |
8066 | 2011 | High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes | Chieh-Lung Cheng ; HSIN-AN HOU ; Jhuang J.-Y.; CHUNG-WU LIN ; Chen, Chien-Yuan ; JIH-LUH TANG ; WEN-CHIEN CHOU ; Tseng M.-H.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | British journal of cancer | 23 | 22 | |
8067 | 2011 | The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia | WEN-CHIEN CHOU ; Lei W.-C.; BOR-SHENG KO ; HSIN-AN HOU ; Chen C.-Y.; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 132 | 132 | |
8068 | 2011 | TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics | WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; HSIN-AN HOU ; Kuo Y.-Y.; Lee M.-C.; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 256 | 235 | |
8069 | 2011 | Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan | Chen, Chien-Yuan ; WANG-HUEI SHENG ; ARISTINE CHENG ; YEE-CHUN CHEN ; WOEI TSAY ; JIH-LUH TANG ; SHANG-YI HUANG ; SHAN-CHWEN CHANG ; HWEI-FANG TIEN | BMC Infectious Diseases | 92 | 80 | |
8070 | 2011 | Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies | Chen, Chien-Yuan ; WANG-HUEI SHENG ; ARISTINE CHENG ; WOEI TSAY ; SHANG-YI HUANG ; JIH-LUH TANG ; YEE-CHUN CHEN ; JANN-YUAN WANG ; HWEI-FANG TIEN ; SHAN-CHWEN CHANG | BMC Infectious Diseases | 34 | 29 | |
8071 | 2010 | The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: A distinct increasing trend with birth-cohort effect | SHANG-JU WU ; SHANG-YI HUANG ; Lin C.-T.; Lin Jr. Y.; Chang C.-J.; HWEI-FANG TIEN | Blood | 56 | 48 | |
8072 | 2010 | WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system | HSIN-AN HOU ; TAI-CHUNG HUANG ; LIANG-IN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 142 | 137 | |
2073 | 2010 | Primary biliary cirrhosis associated with pernicious anemia | Chung C.-S.; Hsu Y.-C.; SHANG-YI HUANG ; YUNG-MING JENG ; CHIEN-HUNG CHEN | Canadian Family Physician | 6 | 5 | |
2074 | 2010 | Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia | HSIN-AN HOU ; TIFFANY TING-FANG SHIH ; Liu C.-Y.; BANG-BIN CHEN ; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; CHAO-YU HSU ; HWEI-FANG TIEN | Haematologica | 14 | 14 | |
2075 | 2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 181 | 173 | |
2076 | 2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 176 | 160 | |
2077 | 2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | JIH-LUH TANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; LIANG-IN LIN ; HWEI-FANG TIEN | Blood | 284 | 255 | |
2078 | 2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | WEN-CHIEN CHOU ; Chen, Chien-Yuan ; HSIN-AN HOU ; LIANG-IN LIN ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 55 | 51 | |
2079 | 2009 | Extramedullary plasmacytoma masquerading as Tolosa-Hunt syndrome: A case report | Ko S.; SHANG-YI HUANG ; Liu C.-Y. | BMJ Case Reports | 5 | 0 | |
2080 | 2009 | Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival | TIFFANY TING-FANG SHIH ; HSIN-AN HOU ; Liu C.-Y.; BANG-BIN CHEN ; JIH-LUH TANG ; Chen H.-Y.; Wei S.-Y.; MING YAO ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; SZU-CHUN HSU ; WOEI TSAY ; CHIH-WEI YU ; CHAO-YU HSU ; HWEI-FANG TIEN ; PAN-CHYR YANG | Blood | 70 | 60 | |
2081 | 2009 | Combination of tissue harmonic sonography, real-time spatial compound sonography and adaptive image processing technique for the detection of carotid plaques and intima-medial thickness | Yen C.-L.; Chang H.-Y.; SHANG-YI HUANG ; Huang Y.-C.; Jeng C.-M. | European Journal of Radiology | 11 | 10 | |
2082 | 2008 | Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Yeh P.-Y.; KUN-HUEI YEH ; YEN-SHEN LU ; SHANG-YI HUANG ; ANN-LII CHENG | Cancer Research | 114 | 105 | |
1083 | 2008 | Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies | TAI-CHUNG HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; CHIUN HSU ; Chen, Chien-Yuan ; WOEI TSAY ; SHANG-YI HUANG ; MING YAO ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; HWEI-FANG TIEN | Leukemia | 47 | 42 | |
1084 | 2007 | Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations | WEN-CHIEN CHOU ; JIH-LUH TANG ; SHANG-JU WU ; WOEI TSAY ; MING YAO ; SHANG-YI HUANG ; KUO-CHIN HUANG ; Chen, Chien-Yuan ; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 94 | 90 | |
1085 | 2007 | Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years | SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WEN-CHUNG LEE ; WOEI TSAY ; ANN-LII CHENG ; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; HWEI-FANG TIEN | Cancer | 86 | 71 | |
1086 | 2006 | 台灣多發性骨髓瘤的研究─流行病學,細胞遺傳學,分子細胞遺傳學和動物模式 | 黃聖懿 ; Huang, Shang-Yi | ||||
1087 | 2004 | Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy | Chen, Chien-Yuan ; JIH-LUH TANG ; PO-REN HSUEH ; MING YAO ; SHANG-YI HUANG ; YEE-CHUN CHEN ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; Tsai W.; SHAN-CHWEN CHANG ; HWEI-FANG TIEN ; KWEN-TAY LUH | Journal of the Formosan Medical Association | 50 | 44 | |
1088 | 2004 | Nonirradiated NOD/SCID-Human Chimeric Animal Model for Primary Human Multiple Myeloma: A Potential in Vivo Culture System | SHANG-YI HUANG ; HWEI-FANG TIEN ; Su F.-H.; Hsu S.-M. | American Journal of Pathology | 22 | 20 | |
1089 | 2003 | Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: Incidence, treatment, and prognosis | Chen, Chien-Yuan ; YEE-CHUN CHEN ; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; Tsai W.; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; HWEI-FANG TIEN | Annals of Hematology | 52 | 33 | |
1090 | 2003 | Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma | SHANG-YI HUANG ; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO ; RUEY-LONG HONG ; Tsai W.; Wang C.-H.; HWEI-FANG TIEN ; MING-CHING SHEN ; YAO-CHANG CHEN | Annals of Hematology | 12 | 10 | |
1091 | 2002 | Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23 | Shiah H.-S.; Kuo Y.-Y.; JIH-LUH TANG ; SHANG-YI HUANG ; MING YAO ; WOEI TSAY ; YAO-CHANG CHEN ; Wang D.-T. C.-H. -au Shen, Lin K.-H.; HWEI-FANG TIEN | Leukemia | 83 | 80 | |
1092 | 2000 | Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: An useful salvage therapy | SHANG-YI HUANG ; CHIH-HSIN YANG ; YAO-CHANG CHEN | Leukemia and Lymphoma | 34 | 34 | |
1093 | 1999 | Minimally differentiated acute myeloid leukemia in Taiwan: Predominantly occurs in children less than 3 years and adults between 51 and 70 years | SHANG-YI HUANG ; JIH-LUH TANG ; SHIANN-TANG JOU ; WOEI TSAY ; Hu C.-H.; DONG-TSAMN LIN ; Lin K.-S.; Lin K.-S.; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; HWEI-FANG TIEN | Leukemia | 13 | ||
1094 | 1999 | Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan | JIN-CHUAN SHEU ; Lin Y.-W.; Chou H.-C.; GUAN-TARN HUANG ; Lee, Hsuan-Shu ; Lin Y.-H.; SHANG-YI HUANG ; CHIEN-HUNG CHEN ; JANN-TAY WANG ; PO-HUANG LEE ; Lin J.-T.; Lu F.-J.; DING-SHINN CHEN | British Journal of Cancer | 63 | 66 | |
1095 | 1998 | Clonal disease of natural killer large granular lymphocytes in Taiwan | WEN-CHIEN CHOU ; Chiang I.-P.; JIH-LUH TANG ; Su I.-J.; SHANG-YI HUANG ; YAO-CHANG CHEN ; Liu M.-C.; Lee F.-Y.U.; Wang C.-H.; MING-CHING SHEN ; Chuang S.-M.; HWEI-FANG TIEN | British Journal of Haematology | 15 | 11 | |
1096 | 1998 | Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia | SHANG-YI HUANG ; Chang C.-S.; JIH-LUH TANG ; HWEI-FANG TIEN ; Kuo T.-L.I.; Huang S.-F.; Yao Y.U.-T.; WEN-CHIEN CHOU ; Chung C.-Y.; Wang C.-H.; MING-CHING SHEN ; YAO-CHANG CHEN | British Journal of Haematology | 105 | 101 | |
1097 | 1997 | Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): A study of four Chinese patients in Taiwan | SHANG-YI HUANG ; JIH-LUH TANG ; Liang Y.-J.; Wang C.-H.; YAO-CHANG CHEN ; HWEI-FANG TIEN | British Journal of Haematology | 41 | 38 |